ARTICLE | Clinical News
Tilarginine acetate injection: Phase III ongoing
May 22, 2006 7:00 AM UTC
A DSMB recommended continuation of the double-blind, placebo-controlled, international Phase III TRIUMPH trial in 658 patients without modification. The recommendation came after data for the first 16...